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Finally, we aimed for a translational validation of our data in cartilage
samples from OA patients.
Methods: Human articular chondrocytes (hACs) stimulated or not with
LiCl were used to carefully map the presence or absence of DOT1L
protein complexes suggested earlier in leukemia cells, using a series of
speciﬁc immunoprecipitation experiments. To elucidate the transcrip-
tional network of Dot1l, we performed a microarray of hACs from 5
non-OA fracture patients treated with a speciﬁc DOT1L inhibitor
(EPZ5676) or vehicle control. The differentially expressed genes were
explored with the limma package. String-DB and Panther were used for
gene network analyses. Based on the microarray analysis, selected
genes were conﬁrmed by quantitative PCR. To establish the role of
DOT1L in the maintenance of hACs phenotype, hACs were cultured in
monolayer in the presence or absence of EPZ5676, and RNA and protein
were isolated at serial passages (P0 to P5). We analyzed by quantitative
PCR the gene expression of known genes important for chondrocyte
biology and/or genes that appeared in the microarray of DOT1L inhib-
ition. Activation of the Wnt canonical and non-canonical signaling
cascades was analyzed by Western blot. For translational validation we
analyzed the differential gene expression proﬁle of damaged as com-
pared to intact cartilage areas within the same joint of patients with hip
OA.
Results: The presence of different DOT1L elongation complexes was
conﬁrmed in hACs. The CoIP experiments revealed that DOT1L interacts
directly with ENL, AF10 and active beta-catenin (more strongly when
cells were treated with LiCl to stabilize beta-catenin) and with AF4 and
AF5 (only with cells were treated with LiCl). The formation of these
complexes was disrupted when DOT1L was inhibited. In the microarray,
1937 genes signiﬁcantly changed (p<0.05) in DOT1L inhibited samples
compared to vehicle treated samples (1048 genes were down-regu-
lated, 889 up-regulated). In EPZ5676 treated samples, chondrocyte
differentiation-associated genes, such as ACAN, RGS5, GDF10 and LOXL2
were down-regulated; OA-related genes, such as MMP1, CCL7, CCL8 and
GPNMB were up-regulated; and WNT target genes, ligands and antag-
onists such as LEF1, WNT5A and DKK1 were signiﬁcantly up-regulated.
In the de-differentiation experiment, in vitro expanded hACs showed
progressive changes in gene expression. Genes involved in relevant
pathways for cartilage biology such as the WNT, NOTCH and BMP
pathways exhibited signiﬁcant changes that were highly accentuated by
DOT1L inhibition. We successfully validated these targets of interest in
samples from patients with OA condition.
Conclusions: Our transcriptomic, protein and gene interaction
approach provides novel insights into the DOT1L molecular network
and its putative role in osteoarthritis and cartilage. These data further
support an important role for DOT1L in joint homeostasis as a key
regulator of WNT signaling and other growth factor cascades in the
joint.
294
DISCRIMINATING BETWEEN PUTATIVE EPIGENETIC OSTEOARTHRITIS
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Purpose: It has become increasingly clear that DNA methylation is
eminently involved in osteoarthritis (OA) pathology, as reﬂected by the
large number of differentially methylated CpGs that have been reported
between healthy, preserved and lesioned articular cartilage. However,
as with the vast number of differentially expressed genes observed in
OA affected articular cartilage, it remains unclear whether these
observed differences are either cause or consequence of the disease. By
combining genome wide methylation, expression and single nucleotide
polymorphism (SNP) datasets we aim to achieve directional insight in
the observed epigenetic and transcriptional changes in OA affected
articular cartilage and report on putative protective and susceptibility
loci.
Methods: Transcriptional activity of CpGs (t-CpGs) was assessed using
genome wide gene expression and DNA methylation data of respec-
tively 33 and 31 pairs of preserved and lesioned articular cartilage.
Disease responsive t-CpGs were identiﬁed by means of differential
methylation between preserved and lesioned cartilage. Additionally, we
addressed proximal SNPs near the OA responsive t-CpGs. Statisticalanalyses were corrected for age, sex, joint and technical covariates,
while a random effect was included to correct for possible correlations
between paired samples.
Results: Of the 9838 transcribed genes in articular cartilage, 2324 cor-
related signiﬁcantly with the methylation status of 3748 t-CpGs , both
canonically negative (N¼1741) as positive (N¼2007) correlations were
observed. Hypomethylation and hypermethylation (FDR<0.05,
jDbj>0.05) were observed for 92 and 59 t-CpGs, respectively, covering
117 unique genes. Signiﬁcant enrichment for developmental and ECM
maintenance pathways was observed, indicating possible reactivation
of endochondral ossiﬁcation. Finally, we observed 11 and 84 OA carti-
lage relevant genes of which, respectively, methylation and expression
is additionally affected by genetic variation. Among others, we here
present the potential disease driving genes ROR2 and CAV1 (ﬁgure 1), as
reﬂected by differential expression between preserved and lesioned
cartilage and, moreover, epigenetic and genetic transcriptional
consequences.
Conclusions: We have shown that OA related epigenetic differences
need to be integrated with other sources of molecular data, such as
genomic and transcriptomic, to enhance our understanding of the
pathophysiological processes of OA. Furthermore, by integration of
multiple layers of genome wide data we have identiﬁed genes, such as
ROR2 and CAV1, which are likely functionally involved in OA patho-
physiology, as opposed to sheer consequence. Although targeting DNA
methylation seems unlikely to stand at the basis for developing treat-
ments, it serves to deepen our understanding of the complex tran-
scriptomic changes in OA affected articular cartilage. Finally, our results
comprise an important step in understanding the reported widespread
epigenetic changes occurring in OA affected articular cartilage.
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Purpose: Genome wide approaches have supplied the osteoarthritis
(OA) ﬁeld with robust susceptibility loci. A number of these risk alleles
act by affecting transcriptional regulation of genes in cis, particularly in
disease relevant tissues. For OA this has been demonstrated previously
for e.g. ALDH1A2, DIO2 and GDF5 by a marked allelic imbalance (AI) in
articular cartilage, a transcriptional phenomenon in which the two
alleles in heterozygous carriers are expressed to unequal extent. Here,
we set out to address the entire articular cartilage transcriptome by
means of RNA sequencing and have assessed AI in all cartilage
expressed genes.
Methods: From 21 patients (6 hips, 15 knees) preserved and lesioned
cartilage were collected. Additionally, from, respectively, 21 (14 hip, 7
knee) and 5 (2 hip, 3 knee) patients, we collected preserved or lesioned
cartilage only. RNA sequencing resulted in 10 million paired-end 100x2
bp long reads per sample. AI was performed on SNPs called using
SNVMix2 with minimum coverage of 25. To avoid rare genetic variants,
only SNPs that were observed in >9 samples were analysed. Fur-
thermore, non-dbSNP A>G SNPs were removed as potential RNA-edit-
ing events. Differential gene expression between preserved and paired
lesioned cartilage was performed using the edgeR package.
Results: We assessed AI in 15216 heterozygous coding SNPs of the
articular cartilage transcriptome and observed that 1175 SNPs tagged AI
of 493 unique genes (FDR<0.05, 0.1<minor/major allele ratio<0.4).
